Evidence map›Paper›PMID 28755158›Full record

ArticleDrug delivery and translational research2018

Optimizing endothelial cell functionalization for cell therapy of vascular proliferative disease using a direct contact co-culture system.

Mark R Battig, Ilia Fishbein, Robert J Levy, Ivan S Alferiev, David Guerrero, Michael Chorny

Open access · greenAbstract read
In one paragraph

Article in Drug delivery and translational research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Cardiovascular delivery of drugs and biotherapeutics.Drug delivery and translational research · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mark R BattigDivision of Cardiology, The Children's Hospital of Philadelphia, and Department of Pediatrics, Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Ilia FishbeinDivision of Cardiology, The Children's Hospital of Philadelphia, and Department of Pediatrics, Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Robert J LevyDivision of Cardiology, The Children's Hospital of Philadelphia, and Department of Pediatrics, Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Ivan S AlferievDivision of Cardiology, The Children's Hospital of Philadelphia, and Department of Pediatrics, Perelman School of Medicine, Philadelphia, PA, 19104, USA.
David GuerreroDivision of Cardiology, The Children's Hospital of Philadelphia, and Department of Pediatrics, Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Michael ChornyDivision of Cardiology, The Children's Hospital of Philadelphia, and Department of Pediatrics, Perelman School of Medicine, Philadelphia, PA, 19104, USA. chorny@email.chop.edu.ORCID 0000-0002-8243-9089
Children's Hospital of Philadelphia · US

Funding

Training in Molecular Therapeutics for Pediatric CardiologyT32HL007915 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI Robert J Levy, JOSEPH W ROSSANO · 1999 to 2026
$13.4M
Uniform field controlled magnetic cell targeting to stentsR01HL111118 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI CHORNY, MICHAEL · 2012 to 2016
$2.1M
Integrated drug-in-cell therapy of in-stent restenosisR21HL131016 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI CHORNY, MICHAEL · 2016 to 2017
$462k
NHLBI NIH HHS R01 HL111118NHLBI NIH HHS R01-HL111118NHLBI NIH HHS R21 HL131016NHLBI NIH HHS R21-HL131016NHLBI NIH HHS T32 HL007915NHLBI NIH HHS T32-HL007915
6 · The paper itself

Abstract

Increased susceptibility to thrombosis, neoatherosclerosis, and restenosis due to incomplete regrowth of the protective endothelial layer remains a critical limitation of the interventional strategies currently used clinically to relieve atherosclerotic obstruction. Rapid recovery of endothelium holds promise for both preventing the thrombotic events and reducing post-angioplasty restenosis, providing the rationale for developing cell delivery strategies for accelerating arterial reendothelialization. The successful translation of experimental cell therapies into clinically viable treatment modalities for restoring vascular endothelium critically depends on identifying strategies for enhancing the functionality of endothelial cells (EC) derived from high cardiovascular risk patients, the target group for the majority of angioplasty procedures. Enhancing EC-associated nitric oxide (NO) synthesis by inducing overexpression of NO synthase (NOS) has shown promise as a way of increasing paracrine activity and restoring function of EC. In the present study, we developed a direct contact co-culture approach compatible with highly labile effectors, such as NO, and applied it for determining the effect of EC functionalization via NOS gene transfer on the growth of co-cultured arterial smooth muscle cells (A10 cell line) exhibiting the defining characteristics of neointimal cells. Bovine aortic endothelial cells magnetically transduced with inducible NOS-encoding adenovirus (Ad) formulated in zinc oleate-based magnetic nanoparticles (MNP[

Indexed as

Cell- and Tissue-Based TherapyCoculture TechniquesEndothelial CellsAnimalsAortaCattleCells, CulturedMagnetite NanoparticlesMyocytes, Smooth MuscleNitric OxideNitric Oxide SynthaseOleic AcidRatsZincMagnetite NanoparticlesNitric OxideNitric Oxide SynthaseOleic AcidZincDirect contact co-culture systemEndothelial cellMagnetic nanoparticleNitric oxideSmooth muscle cellStent angioplasty

Identifiers

PMID28755158
PMCPMC5787406
OpenAlexW2741924529

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.